Loading organizations...
§ Private Profile · Montreal, Canada
SaaS provider developing AI software for pharmaceutical production planning, optimizing processes and resource allocation.
Kaster Technologies, based in Boucherville, Quebec, Canada, develops AI-driven software designed to optimize pharmaceutical production planning. Their platform integrates data, people, and processes to provide real-time decision-making for production sequencing, resource allocation, and scheduling within complex GMP environments. This technology aims to increase production capacity by up to 20% without requiring new equipment, thereby helping address drug shortages and improve operational stability for manufacturers. The company has secured $1.6 million CAD in pre-seed equity funding from lead investors such as Graphite Ventures, Hidden Layers Capital, and Louis-Martin Rousseau. Its client base includes pharmaceutical manufacturers like Delpharm and OPTEL. Kaster Technologies was founded in 2022 by Alexandre Clarizio. Its business model centers on venture-backed SaaS provider selling production planning software to pharmaceutical manufacturers.
Kaster Technologies has raised $117.0M across 1 funding round.
Kaster Technologies has raised $117.0M in total across 1 funding round.
Kaster Technologies has raised $117.0M across 1 funding round. Most recently, it raised $117.0M Pre-Seed in February 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 9, 2026 | $117M Pre Seed | Graphite Ventures | Hidden Layers, Louis Martin Rousseau | Announced |
Kaster Technologies has raised $117.0M in total across 1 funding round.
Kaster Technologies's investors include Graphite Ventures, Hidden Layers, Louis-Martin Rousseau.